ロード中...
Assessing vaccine durability in randomized trials following placebo crossover
Randomized vaccine trials are used to assess vaccine efficacy (VE) and to characterize the durability of vaccine‐induced protection. If efficacy is demonstrated, the treatment of placebo volunteers becomes an issue. For COVID‐19 vaccine trials, there is broad consensus that placebo volunteers should...
保存先:
| 出版年: | Stat Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8242890/ https://ncbi.nlm.nih.gov/pubmed/33928660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.9001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|